Colostrum and Alzheimer's diseases
What is a Alzheimer's disease?
Alzheimer's disease (AD) or simply Alzheimer's, is the most common cause of dementia (AD). Alzheimer's is a progressive and terminal disease, affecting 24 millions people worldwide. The onset of the disease in people occurs over the age 65, but early onset of the disease also exists. It usually beginsa long time before it is actually diagnosed.
Symptoms of Alzheimer's
In the early stages the clearest symptom is short-term memory loss and this leads to confusion, anger, mood swings, language breakdown, long-term memory loss, and decline of all senses.
How our holvita™ colostrum can help people with Alzheimer's
It is thought that Alzheimer's could be caused by an immune disfunction. Colostrum contains special Prolin-Rich-Polypeptide (PRP), which is a powerful regulator of the immune system and increase the permeability of vessels of the skin helping to supply cells with more nutrients.
The importance of regulating the activity of the immune system is that it has the ability to stimulate or suppress the immune response. Suppressing the immune system is necessary to prevent the immune system from attacking the body as “itself”, as is in the case of autoimmune illness, Alzheimer's. Colostrum's suppressive action may help prevent this type of activity involved in autoimmune diseases.
(Beth M.Ley)
In the study by Leszek the results obtained showed that PRP improved the outcome of Alzheimer's patients with mild and moderate dementia.
“The trials demonstrated the therapeutic benefit of CLN (colostrinin proline-rich -polypeptide complex) in Alzheimer's disease (AD) patients by delaying progress of the disease”. (Zimecki)
The fat and casein are removed from our holvita™ liquid colostrum and as a result the level of some of the components, such as PRP, are of a higher concentration. This gives our colostrum the potential to be effective for Alzheimer's disease. Long term use of our holvita™ liquid colostrum extract is recommended.
References
Zimecki M, A proline-rich polypeptide from bovine colostrum: colostrinin with immunomodulatory activity. The trials demonstrated the therapeutic benefit of CLN in Alzheimer's disease (AD) patients by delaying progress of the disease. Institute of Immunology and Experimental Therapy, Wroclaw, Poland. Adv Exp Med Biol. 2008;606:241-50
Sinforiani, E.; et al. Clinical Trials Journal, Vol. 24, No. 1, 1987. Cognitive Decline in Ageing Brain. (Therapeutic Approach with Phosphatidylserine. Brain aging effects were reduced in elderly patients after use of phosphatidylserine, a component of milk & bovine colostrum.
Leszek J, Inglot AD, Janusz M, Byczkiewicz F, Kiejna A, Georgiades J, Lisowski J. Colostrinin proline-rich polypeptide complex from ovine colostrum--a long-term study of its efficacy in Alzheimer's disease. Med Sci Monit. 2002 Oct;8(10):PI93-6.
Nunzi, Maria Grazia; et al. Phospholipids, 1990. Therapeutic Properties of Phosphatidylserine in the Aging Brain. Research results may justify the use of natural phospholipids (a component found in bovine colostrum) as a therapy for treating brain aging.
Bilikiewicz A, Gaus W. Colostrinin (a naturally occurring, proline-rich, polypeptide mixture) in the treatment of Alzheimer's disease. J Alzheimers Dis. 2004 Feb;6(1):17-26.
Beth M.Ley, Ph.D. Immune system control, p78, 1969. (2000) - Book reference